“…One recent breakthrough technology is high-throughput sequencing, which has led to advancements even in small molecule selection. Recent examples of high-throughput sequencing applied to aptamer selection include selections for tyramine (Valenzano et al, 2016), thrombin (Riley et al, 2015), and ovarian cancer biomarkers CA125 and HE4 (Eaton et al, 2015;Scoville, Uhm, Shallcross, & Whelan, 2017). Recent examples of high-throughput sequencing applied to aptamer selection include selections for tyramine (Valenzano et al, 2016), thrombin (Riley et al, 2015), and ovarian cancer biomarkers CA125 and HE4 (Eaton et al, 2015;Scoville, Uhm, Shallcross, & Whelan, 2017).…”